Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy
- 1 September 2001
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 50 (6) , 463-467
- https://doi.org/10.1016/s0006-3223(01)01190-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findingsZeitschrift für Neurologie, 2001
- Vulnerability of the nigrostriatal system as detected by transcranial ultrasoundNeurology, 1999
- Iron accumulation in the substantia nigra in rats visualized by ultrasoundUltrasound in Medicine & Biology, 1999
- Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patientsThe Journal of Neuropsychiatry and Clinical Neurosciences, 1997
- Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonographyNeurology, 1995
- Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?Journal of Neurochemistry, 1994
- Nigral dysfunction in drug‐induced parkinsonismNeurology, 1993
- Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesiaSchizophrenia Research, 1991
- Neuroleptic-induced parkinsonism in older schizophrenicsBiological Psychiatry, 1987
- Extrapyramidal effects of neuroleptics.Journal of Neurology, Neurosurgery & Psychiatry, 1976